ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 0207 • ACR Convergence 2024

    Investigation of Delays in Cancer Screening in RA

    Rebecca Brooks1, Cassondra Hulshizer2, Andrew C. Hanson3, Vanessa Kronzer1, John Davis1, Elena Myasoedova1 and Cynthia Crowson1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Utica, MN, 3Mayo Clinic, Rochester

    Background/Purpose: Recent studies have shown that RA patients have increased mortality due to cancer. Despite the increased mortality, few studies have investigated the completion of…
  • Abstract Number: 1039 • ACR Convergence 2024

    Through the LuCIN Lens: Defining Barriers and Forging Solutions for Lupus Clinical Trials in North America

    Brandon Jackson1, Maria Dall'Era2, Saira Sheikh3, Xueting Zhang4, Taylor Irons5, Jennifer Meriwether6, Maya Merrell1 and Stacie Bell7, 1Lupus Research Alliance / Lupus Therapeutics, Miami, FL, 2UCSF, Corte Madera, CA, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Weill Cornell, New York, NY, 5Lupus Research Alliance / Lupus Therapeutics, Houston, 6Lupus Research Alliance / Lupus Therapeutics, New York, NY, 7Lupus Therapeutics, Lakewood, CO

    Background/Purpose: Lupus Therapeutics (LT), the clinical affiliate of the Lupus Research Alliance, oversees the Lupus Clinical Investigators Network (LuCIN), a network of premier research sites…
  • Abstract Number: 1360 • ACR Convergence 2024

    Impact of Maintaining Low Disease Activity on Patient Outcomes and Healthcare Resource Utilization in Rheumatoid Arthritis Patients Receiving Advanced Treatment

    Urbano Sbarigia1, Jing Zhao2, Jackie Kwong2, Chinmayi Naik3, Federico Zazzetti4, Nancy Shadick3 and Michael Weinblatt5, 1Johnson & Johnson Innovative Medicine, Brussels, Belgium, 2Janssen Global Services, LLC, a Johnson & Johnson Company, Raritan, NJ, 3Brigham and Women’s Hospital, Boston, MA, 4Johnson & Johnson Innovative Medicine, Horsham, PA, PA, 5Brigham and Women's Hospital/ Harvard Medical School, Waban, MA

    Background/Purpose: Despite scientific advances and the availability of new treatments for rheumatoid arthritis (RA), many RA patients still cannot achieve the therapeutic goal of low…
  • Abstract Number: 1946 • ACR Convergence 2024

    Shaping the Future of the National Musculoskeletal (MSK) Triage Initiative: Exploring the Impact of a Hybrid Model (Virtual and Face to Face) of MSK Triage

    Julie Sugrue, Scott Murphy, Mark Kingston, paula Wallace, Catriona O'Dwyer, colum Moloney, Olivia McKenna, Finbarr Condon and Sean McKenna, Health Service Executive, Limerick, Limerick, Ireland

    Background/Purpose: Rheumatic and musculoskeletal diseases (RMDs) are the leading contributor of disability worldwide (de Thurah et al 2022). The National Musculoskeletal (MSK) Triage Initiative, ensures…
  • Abstract Number: 0212 • ACR Convergence 2024

    Costs of Hospitalization in Patients with SLE: An Analysis of the National Inpatient Sample

    Brandon Blau1, Kelsey Gripp1, Catherine MacLean2 and Bella Mehta2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is associated with significant health care utilization, medical costs, and increased risk of hospitalization. We aimed to characterize the reasons…
  • Abstract Number: 1040 • ACR Convergence 2024

    Clinic Personnel Perceptions Were Favorable for the Implementation of a Patient Decision-Aid for a Diverse Systemic Lupus Erythematosus Population: A Study in 15 U.S. Rheumatology Clinics

    Jasvinder Singh1, Larry Hearld2, Walter Chatham3, Sonali Narain4, Narender Annapureddy5, Diane Kamen6, Kimberly Trotter7, vikas Majithia8, Cathy Lee Ching9, Zineb Aouhab10, Swamy Venuturupalli11, Daniel Wallace12, rosalind Ramsey-Goldman13, Alfred Kim14, Maureen McMahon15, S. Sam Lim16, Kalpana Bhairavarasu17, Alexa Meara18 and Kenneth Kalunian19, 1Baylor College of Medicine, Birmingham, AL, 2University of Alabama at Birmingham (UAB), Birmingham, AL, 3University of Nevada, Las Vegas, Las Vegas, NV, 4Northwell Health, Great Neck, NY, 5Vanderbilt University Medical Center, Nashville, TN, 6Medical University of South Carolina, Charleston, SC, 7University of Chicago, Chicago, IL, 8University of Missisippi Medical Center (UMC), Jackson, MS, 9UMMC, Jackson, MS, 10Loyola University Medical Center, Oak Brook, IL, 11Attune Health, Beverly Hills, CA, 12Cedars Sinai Medical Center, Studio City, CA, 13Northwestern University, Chicago, IL, 14Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO, 15UCLA David Geffen School of Medicine, Los Angeles, CA, 16Emory University, Atlanta, GA, 17Baylor College of Medicine, Sugar Land, TX, 18The Ohio State University Wexner Medical Center, COLUMBUS, OH, 19University of California San Diego, La Jolla, CA

    Background/Purpose: To understand clinic personnel feedback regarding the implementation of a self-administered patient decision-aid (PtDA) for lupus in regular, outpatient rheumatology clinics.Methods: We provided self-administered…
  • Abstract Number: 1689 • ACR Convergence 2024

    Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic Sclerosis

    Kamini Kuchinad1, Rachel Wallwork2, Matthew Lammi3, Christopher Mecoli1, Julie Paik1, Fredrick Wigley4, Robert Wise1, Laura Hummers5, Ami Shah6 and Ji Soo Kim1, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Towson, MD, 3Johns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, MD, 4Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Baltimore, MD, 5Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Ellicott City, MD, 6Division of Rheumatology, Johns Hopkins University, Ellicott City, MD

    Background/Purpose: Black individuals with systemic sclerosis (SSc) have an increased frequency and severity of interstitial lung disease (ILD) as compared to their White counterparts. Pulmonary…
  • Abstract Number: 1947 • ACR Convergence 2024

    Optimizing Osteoarthritis Care Through Clinical and Community Partnership: Results of an Exploratory Trial

    Kelli Allen1, Liubov Arbeeva2, Leigh Callahan3, Katherine Combs4, Tamara Godfrey5, Yvonne Golightly6, Derek Hales5, Carla Hill7, Katie Huffman8, Amanda Nelson5, Jennifer Rees5 and Todd Schwartz9, 1University of North Carolina, Durham, NC, 2University of North Carolina, Chapel Hill, Carrboro, NC, 3University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 4YMCA of the Triangle, Raleigh, NC, 5University of North Carolina at Chapel HIll, Chapel Hill, NC, 6University of Nebraska Medical Center, Omaha, NE, 7UNC Health, Raleigh, NC, 8UNC Thurston Arthritis Research Center, Chapel Hill, NC, 9University of North Carolina-Chapel Hill, Chapel Hill, NC

    Background/Purpose: Many studies have documented gaps in quality of care for knee and hip osteoarthritis (OA), particularly with respect to lifestyle (e.g., weight management, exercise)…
  • Abstract Number: 0213 • ACR Convergence 2024

    Electronic Medical Record Inbox Volume Association with Physician Gender, Physician Burnout, and the COVID-19 Pandemic at an Academic Rheumatology Center

    Laura Arneson1, Brian Jaros2, Rowland Chang2, Anisha Dua2, Lutfiyya Muhammad3, Anh Chung2 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern University Division of Rheumatology, Chicago, IL, 3Northwestern Feinberg School of Medicine, Chicago, IL

    Background/Purpose: As Rheumatology faces a workforce shortage, factors contributing to physician burnout are crucial to address. Research in other specialties suggests that increased electronic medical…
  • Abstract Number: 1041 • ACR Convergence 2024

    A Theory of Change for Patient-Initiated Follow-Up Care in Rheumatoid Arthritis

    Manuel Ester1, Krista White2, Kiran Dhiman2, Saania Zafar2, Alexandra Charlton3, Glen Hazlewood4, Gabrielle L. Zimmermann5, Alison Hoens6, Sarah L. Manske7, Diane Lacaille8, Mark G. Perry9, Megan R.W. Barber10, Aurore Fifi-Mah4, Niki Panich11, Monika Szpunar12, Karen Then13, Kelly Osinski14, Shakeel Subdar15, Hafsah Al-Azem16, Michelle Jung16 and Claire Barber4, 1McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary; O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary; Arthritis Research Canada, Calgary, AB, Canada, 2McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3Division of Rheumatology, Cumming School of Medicine, Calgaru, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5Alberta SPOR SUPPORT Unit – Learning Health System Team, Department of Medicine, University of Alberta; 6. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Edmonton, AB, Canada, 6Arthritis Research Canada; Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, 7McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary; Department of Radiology, University of Calgary, Calgary, AB, Canada, 8Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 9Department of Rheumatology, University Hospitals Plymouth; Peninsula Medical School, Plymouth, England, United Kingdom, 10Arthritis Research Canada; Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada, 11Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 12Arthritis Research Canada, Toronto, ON, Canada, 13Faculty of Nursing, University of Calgary, Calgary, AB, Canada, 14Alberta Health Services, Edmonton, AB, Canada, 15Temerty School of Medicine, University of Toronto, Toronto, ON, Canada, 16Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada

    Background/Purpose: Timely, high-quality care is critical to effective rheumatoid arthritis (RA) management. Due to the resource-intensive nature of routine lifelong follow-ups and rheumatologist shortages, RA…
  • Abstract Number: 1714 • ACR Convergence 2024

    Avoidable Hospitalizations by Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

    Dani Contreras1, Claire Barber1, J. Antonio Avina-Zubieta2, Hude Quan1, Seungwon Lee1, James King1 and Cheryl Barnabe1, 1University of Calgary, Calgary, AB, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Ambulatory care sensitive conditions (ACSCs) are conditions where appropriate access to ambulatory care can reduce hospitalizations. People with rheumatoid arthritis (RA) are at higher…
  • Abstract Number: 2409 • ACR Convergence 2024

    Adherence to EULAR Recommendations and Sub Optimal Management of Systemic Lupus Erythematosus in a Network of Community-Based Rheumatology Practices in the United States

    Jeffrey Curtis1, Emily Holladay2, Amy Mudano3, Emily Smitherman4, Fenglong xie5, Shanette G. Daigle6, Yujie Su3, Mawuena Binka7, Gelareh Atefi8, Rana Muhammad Qasim Khan9 and Tope Olufade10, 1Illumination Health, Birmingham, AL, 2University of Alabama at Birmingham, Edmond, OK, 3Illumination Health, Hoover, AL, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham; Illumination Health, Birmingham, AL, 6Foundation for Advancing Science, Technology, Education, and Research, Birmingham, 7BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, 8AstraZeneca, Media, PA, 9BioPharmaceuticals Medical, AstraZeneca, Wilmington, 10AstraZeneca, Wilmington, DE

    Background/Purpose: Despite new developments in systemic lupus erythematosus (SLE) treatment and treatment guidelines, the clinical management of SLE is often sub-optimal. We aimed to describe…
  • Abstract Number: 0215 • ACR Convergence 2024

    BP Connect Improves Follow-up of High Blood Pressure in Urban Rheumatology and Non-Rheumatology Clinics

    Alexa Figueroa Baiges1, David Gazeley2, Monica Messina1, Bret Hanlon3, Edmond Ramly4, Ann Rosenthal5, Laura Stewart6, Makeba Williams7, Heidi W. Brown8 and Christie Bartels9, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Medical College of Wisconsin, Wauwatosa, WI, 3Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Indiana University School of Public Health, Bloomington, IN, 5Medical College of Wisconsin, Milwaukee, WI, 6Froedtert and Medical College of Wisconsin, Milwaukee, WI, 7Washington University in St. Louis School of Medicine, St. Louis, MO, 8Division of Health Services Research & Implementation Science, Kaiser Permanente, San Diego, CA, 9University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hypertension accounts for >54% of modifiable cardiovascular disease (CVD) risk and although 49% of US outpatient visits occur in specialty clinics, only 10% of…
  • Abstract Number: 1042 • ACR Convergence 2024

    Identifying Patient Priorities for Patient-Reported Outcome Measures in Rheumatoid Arthritis: A Modified Delphi Consensus Study

    Racheal Githumbi1, Steven Katz2, Ania Kania-Richmond1, Kim Giroux3, Yvonne Wallace3, Cheryl Barnabe1, Glen Hazlewood1, C. Allyson Jones2, Amanda Steiman4, Anshula Ambasta1, Diane Lacaille5, Elaine Yacyshyn2, Jessica Widdifield6, Natasha Gakhal7, Tyler Williamson1 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Patient Partner, Calgary, AB, Canada, 4Sinai Health System, Toronto, ON, Canada, 5Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 6Sunnybrook Research Institute / ICES / UofT Institute of Health Policy, Management & Evaluation, Toronto, ON, Canada, 7Women's College Hospital, Toronto, ON, Canada

    Background/Purpose: Patient-reported outcome measures (PROMs) are essential tools for prioritizing patient-centric care and enhancing health system-performance measurement in rheumatology. Effective use of PROMs collected in…
  • Abstract Number: 1719 • ACR Convergence 2024

    Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis: A Nested Case-Control Study

    Beth Wallace1, Yuqing Gao2, H. Myra Kim3, Bryant England4, Sauer brian5, grant Cannon6, Punyasha Roul7, Ted Mikuls4, Shirley Cohen-Mekelburg8, Daniel Clauw9, Wyndy Wiitala2, Rodney Hayward10, Jeremy Sussman11 and Akbar Waljee11, 1Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 2Center for Clinical Management Research, Department of Veterans Affairs, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3University of Michigan School of Public Health, Ann Arbor, MI, 4University of Nebraska Medical Center, Omaha, NE, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6University of Utah and Salt Lake City VA, Salt Lake City, UT, 7UNMC, Omaha, NE, 8University of Michigan Department of Internal Medicine, Division of Gastroenterology, Ann Arbor, MI, 9University of Michigan, Whitmore Lake, MI, 10Department of Internal Medicine, University of Michigan; Center for Clinical Management Research, Department of Veterans Affairs, VA Ann Arbor Healthcare System, Ann Arbor, MI, 11Internal Medicine and Center for Clinical Management Research, Department of Veterans Affairs, VA Ann Arbor Healthcare System, Ann Arbor, MI

    Background/Purpose: Three-quarters of RA patients use glucocorticoids (GC) to manage RA symptoms. Our work presented previously suggests recent GC use (up to 2 years prior…
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology